A case of cerebral infarct in combined antiphospholipid antibody and ovarian hyperstimulation syndrome.

Ovarian hyperstimulation syndrome is a serious complication of ovulation induction and has a diverse clinical spectrum from edema to thromboembolism. Antiphospholipid antibody syndrome, one of the well known hypercoagulable states, can be also manifested as an arterial or venous thrombosis and recurrent spontaneous abortion. Sometimes a patient with antiphospholipid antibodies might not notice a miscarriage and seek for assisted reproduction treatment, which harbors a chance of developing ovarian hyperstimulation syndrome. If this happens, the ovarian hyperstimulation syndrome can exacerbate the thrombotic complication of underlying antiphospholipid antibody syndrome, resulting in a catastrophic vascular event. The authors experienced a case of middle cerebral artery infarct, which developed during ovarian hyperstimulation syndrome in a 33-yr-old woman with a previous history of fetal loss. An elevated titer of anticardiolipin antibodies was noticed and persisted thereafter. The authors suggest screening tests for the presence of antiphospholipid antibodies before controlled ovarian hyperstimulation.

[1]  B. Coull,et al.  Coagulation Abnormalities in Stroke , 2004 .

[2]  J. Buyon,et al.  Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. , 2000, Arthritis and rheumatism.

[3]  F. Yoshii,et al.  Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome , 1999, Neurology.

[4]  G. Serour,et al.  Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis. , 1998, Human reproduction.

[5]  M. M. El Sadek,et al.  Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome. , 1998, Human reproduction.

[6]  J. Piette,et al.  Can we advise ovulation induction in patients with SLE? , 1998, Scandinavian journal of rheumatology. Supplement.

[7]  A. Murdoch,et al.  Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. , 1997, Human reproduction.

[8]  J. Fukuda,et al.  Activation of plasma kinin system correlates with severe coagulation disorders in patients with ovarian hyperstimulation syndrome. , 1997, Human reproduction.

[9]  J. Piette,et al.  Risks of ovulation-induction therapy in systemic lupus erythematosus. , 1996, British journal of rheumatology.

[10]  H. Karube,et al.  Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. , 1996, Fertility and sterility.

[11]  J. Balasch Correction to “Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.” , 1993 .

[12]  N. Laufer,et al.  Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment , 1993 .